| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |